BIIB068
- CAS No.
- 1798787-27-5
- Chemical Name:
- BIIB068
- Synonyms
- BIIB068;BIIB-068;BIIB068, 10 mM in DMSO;3-Isopropoxy-N-(2-methyl-4-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)benzyl)azetidine-1-carboxamide;N-[(2-methyl-4-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}phenyl)methyl]-3-(propan-2-yloxy)azetidine-1-carboxamide;1-Azetidinecarboxamide, 3-(1-methylethoxy)-N-[[2-methyl-4-[2-[(1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]phenyl]methyl]-;ADME,inhibit,FcγR,Autoimmune,Bruton tyrosine kinase,TNFα,BIIB 068,ROS,Inhibitor,reversible,Btk,anti-IgD,phosphorylation,BIIB068,anti-IgM,BIIB-068
- CBNumber:
- CB45853001
- Molecular Formula:
- C23H29N7O2
- Molecular Weight:
- 435.52
- MDL Number:
- MOL File:
- 1798787-27-5.mol
Density | 1.30±0.1 g/cm3(Predicted) |
---|---|
solubility |
DMSO:30.63(Max Conc. mg/mL);70.33(Max Conc. mM) DMSO:PBS (pH 7.2) (1:4):0.2(Max Conc. mg/mL);0.46(Max Conc. mM) DMF:30.0(Max Conc. mg/mL);68.88(Max Conc. mM) Ethanol:10.0(Max Conc. mg/mL);22.96(Max Conc. mM) |
form | A crystalline solid |
pka | 13.40±0.40(Predicted) |
color | Off-white to yellow |
FDA UNII | M6RN4LQ25S |
BIIB068 price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
ChemScene | CS-0133440 | BIIB068 99.20% | 1798787-27-5 | 5mg | $180 | 2021-12-16 | Buy |
ChemScene | CS-0133440 | BIIB068 99.20% | 1798787-27-5 | 10mg | $300 | 2021-12-16 | Buy |
ChemScene | CS-0133440 | BIIB068 99.20% | 1798787-27-5 | 25mg | $550 | 2021-12-16 | Buy |
ChemScene | CS-0133440 | BIIB068 99.20% | 1798787-27-5 | 50mg | $950 | 2021-12-16 | Buy |
ChemScene | CS-0133440 | BIIB068 99.20% | 1798787-27-5 | 100mg | $1650 | 2021-12-16 | Buy |
BIIB068 Chemical Properties,Uses,Production
Uses
BIIB068 is a potent, selective, reversible and orally active BTK inhibitor with an IC50 of 1 nM and a Kd of 0.3 nM. BIIB068 shows more >400-fold selective for BTK than other kinases. BIIB068 has the potential for autoimmune diseases research[1].
in vivo
BIIB068 (compound 1) is stable in the plasma of mouse, rat, beagle dog, and cynomolgus monkey (>95% parent compound remaining after 6 hours of incubation)[1].
BIIB068 (compound 1) exhibits good drug-like properties (LLE = 5) which results in low in vivo clearance (CL %Qh = 6) and moderate oral bioavailability (%F = 48) when dosed in rats. BIIB068 (5 mg/kg; po) treatment shows the T1/2 of 1.2 hours, 2.1 hours and 0.9 hour for rats, dog and cynomolgus monkey, respectively. BIIB068 shows acceptable ADME (absorption, distribution, metabolism, and excretion) properties[1].
References
[1] Bin Ma, Tonika Bohnert, et al. Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases. J Med Chem. 2020 Jul 22. DOI:10.1021/acs.jmedchem.0c00702
BIIB068 Preparation Products And Raw materials
Raw materials
Preparation Products
BIIB068 Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 33024 | 60 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32159 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38630 | 58 | |
Suzhou ARTK Medchem Co., Ltd. | +86-512-68323658 +86-18168183658 | sales1@artkmedchem.com | China | 39003 | 58 |
BOC Sciences | 1-631-485-4226; 16314854226 | info@bocsci.com | United States | 12952 | 65 |
Shanghai XingMo Biotechnology Co., Ltd. | +86 13524779951; 13524779951 | 2075692521@qq.com | China | 310 | 55 |
Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696,15000506266 15000506266 | China | 4601 | 55 | |
Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9803 | 58 |
AgileBioChem Co., Ltd. | 18055517827 | sales@agilebiochem.com | China | 999 | 50 |
Shanghai Chaolan Chemical Technology Center | 021-QQ:65489617 15618227136 | Sales@ATKchemical.com | China | 9329 | 58 |